Market Place
Sourcing Support
Statera Biopharma gets the OK to resume the study of a potential stockpile drug
02 Dec 2021 //
ENDPTS
Cytocom to Become Statera BioPharma
01 Sep 2021 //
CONTRACT PHARMA
Cytocom to Become Statera BioPharma
31 Aug 2021 //
CONTRACT PHARMA
Cytocom, Inc. Reports Second Quarter 2021 Financial Results
16 Aug 2021 //
PR NEWSWIRE
Cytocom to fund laboratory facilities at La Jolla Institute for Immunology
14 Aug 2021 //
PHARMABIZ
Cytocom to Fund Research and Lab Facilities at the La Jolla Institute
13 Aug 2021 //
CONTRACT PHARMA
Cytocom, Inc. and La Jolla Institute for Immunology Announce Agreement
12 Aug 2021 //
PRNEWSWIRE
Cytocom Inc. Provides Update on Completed Merger with Cleveland BioLabs
05 Aug 2021 //
PRNEWSWIRE
Cleveland and Cytocom Announce Registration Statement and Proxy Statement
17 Jun 2021 //
BIOSPACE
Cytocom Receives FDA Clearance of IND for Phase 2 Clinical Trial of CYTO-205
16 Mar 2021 //
PRNEWSWIRE
Cytocom Gets FDA Clearance for Phase II Trial of COVID Immune Therapy
16 Mar 2021 //
CONTRACTPHARMA
Cytocom and Cleveland Biolabs Merge
20 Oct 2020 //
CONTRACTPHARMA
Cytocom and Cleveland BioLabs Announce Definitive Merger Agreement
20 Oct 2020 //
BIOSPACE
Immune, Announces Signing of Definitive Merger Agreement Between Cytocom
20 Oct 2020 //
BIOSPACE
Cytocom and Cleveland BioLabs Announce Definitive Merger Agreement
20 Oct 2020 //
PRNEWSWIRE
Cytocom and Cleveland BioLabs Announce Definitive Merger Agreement
19 Oct 2020 //
ACCESSWIRE
Cytocom, Announces Agreement to Reacquire Rights to Lead Drug Candidate CYTO-201
20 Aug 2020 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.